T Cell-Derived IL-17A Induces Vascular Dysfunction via Perivascular Fibrosis Formation and Dysregulation of


Journal

Oxidative medicine and cellular longevity
ISSN: 1942-0994
Titre abrégé: Oxid Med Cell Longev
Pays: United States
ID NLM: 101479826

Informations de publication

Date de publication:
2019
Historique:
received: 10 04 2019
accepted: 27 05 2019
entrez: 10 8 2019
pubmed: 10 8 2019
medline: 4 1 2020
Statut: epublish

Résumé

The neutrophil recruiting cytokine Interleukin-17A (IL-17A) is a key component in vascular dysfunction and arterial hypertension. Moreover, IL-17A has a central role for the vascular infiltration of myeloid cells into the arterial wall in Angiotensin II-induced vascular inflammation. The intention of our study was to analyze the impact of T cell-derived IL-17A on hypertension, vascular function, and inflammation. Chronic IL-17A overexpression in T cells (CD4-IL-17A Our data demonstrate that T cell-derived IL-17A elicits vascular dysfunction by mediating proliferation of fibroblasts and subsequent vascular fibrosis associated with PYK2 upregulation.

Identifiants

pubmed: 31396305
doi: 10.1155/2019/6721531
pmc: PMC6668561
doi:

Substances chimiques

Interleukin-17 0
Protein Subunits 0
Reactive Oxygen Species 0
Nitric Oxide 31C4KY9ESH
Focal Adhesion Kinase 2 EC 2.7.10.2
Soluble Guanylyl Cyclase EC 4.6.1.2
Cyclic GMP H2D2X058MU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6721531

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

Circ Res. 2000 Nov 24;87(11):999-1005
pubmed: 11090544
Immunity. 2001 Nov;15(5):763-74
pubmed: 11728338
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1755-7
pubmed: 12426200
J Biol Chem. 2003 Jun 20;278(25):22546-54
pubmed: 12692136
Free Radic Biol Med. 2004 Jan 1;36(1):101-11
pubmed: 14732294
Nat Immunol. 2004 Aug;5(8):818-27
pubmed: 15258578
J Clin Invest. 2006 May;116(5):1218-22
pubmed: 16670765
Hypertension. 2006 Oct;48(4):677-84
pubmed: 16940222
J Immunol. 2006 Oct 1;177(7):4662-9
pubmed: 16982905
J Exp Med. 2007 Oct 1;204(10):2449-60
pubmed: 17875676
J Clin Invest. 2009 Jan;119(1):61-9
pubmed: 19075395
Annu Rev Immunol. 2009;27:485-517
pubmed: 19132915
J Exp Med. 2009 Sep 28;206(10):2067-77
pubmed: 19737863
J Exp Med. 2009 Dec 21;206(13):2889-96
pubmed: 19934023
FASEB J. 2010 Apr;24(4):1023-34
pubmed: 19940258
J Immunol. 2009 Dec 15;183(12):8167-75
pubmed: 20007582
Hypertension. 2010 Feb;55(2):500-7
pubmed: 20038749
J Invest Dermatol. 2010 Apr;130(4):919-22
pubmed: 20231829
Immunity. 2011 Feb 25;34(2):149-62
pubmed: 21349428
J Invest Dermatol. 2011 May;131(5):1007-10
pubmed: 21494241
Circulation. 2011 Sep 20;124(12):1370-81
pubmed: 21875910
Nat Protoc. 2011 Dec 22;7(1):89-104
pubmed: 22193302
Cardiovasc Res. 2013 Mar 15;97(4):696-704
pubmed: 23263331
Cytokine. 2013 May;62(2):195-201
pubmed: 23562549
Antioxid Redox Signal. 2014 Jan 10;20(2):247-66
pubmed: 23845067
Circ Res. 2014 Feb 14;114(4):616-25
pubmed: 24347665
J Biol Chem. 2014 Oct 3;289(40):27540-50
pubmed: 25143378
Arterioscler Thromb Vasc Biol. 2014 Dec;34(12):2658-68
pubmed: 25341795
J Biol Chem. 2016 Mar 4;291(10):4939-54
pubmed: 26733204
PLoS One. 2016 Feb 11;11(2):e0149231
pubmed: 26866924
Antioxid Redox Signal. 2017 Jan 20;26(3):122-136
pubmed: 26972233
J Clin Invest. 2016 Apr 1;126(4):1607
pubmed: 27035819
Hypertension. 2016 Jun;67(6):1218-27
pubmed: 27067720
Pharmacol Res Perspect. 2016 Sep 16;4(5):e00261
pubmed: 27713826
JACC Basic Transl Sci. 2016 Dec;1(7):606-616
pubmed: 28280792
J Dent Res. 2018 Oct;97(11):1214-1221
pubmed: 29775416
J Mol Med (Berl). 2018 Aug;96(8):819-829
pubmed: 29959474
Biomed Pharmacother. 2018 Nov;107:1196-1204
pubmed: 30257333
Circ Res. 2018 Aug 3;123(4):477-494
pubmed: 30355249
J Invest Dermatol. 2019 Mar;139(3):638-647
pubmed: 30367871
Am J Physiol Lung Cell Mol Physiol. 2019 Mar 1;316(3):L487-L497
pubmed: 30604628
J Immunol. 1995 Dec 15;155(12):5483-6
pubmed: 7499828
Proc Natl Acad Sci U S A. 1995 May 23;92(11):5244-8
pubmed: 7539147

Auteurs

Rebecca Schüler (R)

Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz, Mainz, Germany.
Institute for Molecular Medicine, University Medical Center Mainz, Mainz, Germany.

Panagiotis Efentakis (P)

Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz, Mainz, Germany.

Johannes Wild (J)

Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz, Mainz, Germany.
Center for Cardiology-Cardiology I, University Medical Center Mainz, Mainz, Germany.

Jérémy Lagrange (J)

Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz, Mainz, Germany.

Venkata Garlapati (V)

Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz, Mainz, Germany.

Michael Molitor (M)

Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz, Mainz, Germany.
Center for Cardiology-Cardiology I, University Medical Center Mainz, Mainz, Germany.
German Center for Cardiovascular Research (DZHK)-Partner Site Rhine-Main, Germany.

Sabine Kossmann (S)

Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz, Mainz, Germany.
Center for Cardiology-Cardiology I, University Medical Center Mainz, Mainz, Germany.

Matthias Oelze (M)

Center for Cardiology-Cardiology I, University Medical Center Mainz, Mainz, Germany.

Paul Stamm (P)

Center for Cardiology-Cardiology I, University Medical Center Mainz, Mainz, Germany.

Huige Li (H)

Department of Pharmacology, University Medical Center Mainz, Mainz, Germany.

Katrin Schäfer (K)

Center for Cardiology-Cardiology I, University Medical Center Mainz, Mainz, Germany.

Thomas Münzel (T)

Center for Cardiology-Cardiology I, University Medical Center Mainz, Mainz, Germany.
German Center for Cardiovascular Research (DZHK)-Partner Site Rhine-Main, Germany.

Andreas Daiber (A)

Center for Cardiology-Cardiology I, University Medical Center Mainz, Mainz, Germany.
German Center for Cardiovascular Research (DZHK)-Partner Site Rhine-Main, Germany.

Ari Waisman (A)

Institute for Molecular Medicine, University Medical Center Mainz, Mainz, Germany.

Philip Wenzel (P)

Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz, Mainz, Germany.
Center for Cardiology-Cardiology I, University Medical Center Mainz, Mainz, Germany.
German Center for Cardiovascular Research (DZHK)-Partner Site Rhine-Main, Germany.

Susanne Helena Karbach (SH)

Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz, Mainz, Germany.
Center for Cardiology-Cardiology I, University Medical Center Mainz, Mainz, Germany.
German Center for Cardiovascular Research (DZHK)-Partner Site Rhine-Main, Germany.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH